Illinois Cases To Watch In 2023: A Midyear Report
A jury will decide appropriate damages for biometric privacy violations, federal antitrust regulators will put a relatively novel pharmaceutical theory to the test and nursing homes in the state will learn...To view the full article, register now.
Already a subscriber? Click here to view full article